Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients

Summary

This study is a Randomized, Double-Blind, Placebo-Controlled Trial. The objective of the study is to assess the effect of doxycycline in levodopa treated Parkinson's disease patients regarding motor performance and cognitive functions. Parkinson's disease patients on levodopa medications will be assigned to receive doxycycline 50mg twice daily or placebo over 8 weeks. The motor and cognitive symptoms of Parkinson's disease will be assessed after 4 weeks and 8 weeks follow up.

Timeline

Start

2022-07-01

Primary completion

2023-01-01

Completion

2023-01-01

Drugs

Indications